Thursday, March 21, 2013

Daily Business Update

 
To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.
If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
 
EDITORIAL EMAIL PUBLISHED BY   Boston.com
Daily Business Update Thu. Mar. 21, 2013
 
Want scrod & oysters at Logan? No problem. New Durgin-Park eatery’s got you covered
According to a recent report by a dating website, Logan International Airport is a hotbed for romance, and now it may be evolving into a hotbed for New England cuisine as well. Durgin-Park, an iconic Hub restaurant known for scrod, chowder, and the occasional waitress with a nuts-to-you attitude, is now serving up regional delicacies at a 3,405-square-foot restaurant at Logan’s Terminal E, said AirMall USA, a company that operates concessions at Logan and several other airports. ‘‘At AirMall, we think it’s vital to add restaurants and shops to our concessions programs that reflect the area and give travelers a sense of the region’s history, flavor, and flair,’’ Michael Caro, vice president of AirMall Boston, said.
Mass. unemployment rate for February drops to 6.5 percent
The Massachusetts unemployment rate dropped to 6.5 percent in February, down from 6.7 percent in January, as the local economy created 500 jobs last month, the state's Executive Office of Labor and Workforce Development reported Thursday.
Dave Ellenberger appointed CEO of Pursway
Pursway Ltd., a marketing analytics firm with offices in Waltham and Israel, said Thursday that Dave Ellenberger has been appointed chief executive; the appointment comes as the company moves into its next phase of growth.
bluebird bio forms cancer drug partnership with Celgene
Cambridge biotechnology company bluebird bio announced Thursday the formation of a global collaboration with Celgene Corp. to discover, develop, and commercialize gene therapies for oncology treatments.
Tetraphase shares unchanged on first day of trading after $75 million IPO
Tetraphase Pharmaceuticals Inc. stock closed unchanged at $7 a share on its first day of trading on the Nasdaq exchange Wednesday after the Watertown biotechnology start-up raised $74.9 million in an initial public offering.
Tufts doctors raise funding for start-up working on treatment for age-related blindness; Firemans among funders
Hemera Biosciences, a Boston start-up company that’s working on a treatment for age-related blindness, has raised $3.8 million in investment funding to further study its gene remedy for the affliction. Age-related macular degeneration typically affects people over age 55 and is the leading cause of blindness in the United States and Europe, the company said. Approximately 8 million people in this country have a form of the disease, Hemera said. The company’s founders are doctors and faculty members at the Tufts University School of Medicine in Boston.
NH defense, aerospace firms eye expanded exports
New Hampshire’s aerospace and defense industry companies are working together to find opportunities overseas. The New Hampshire Aerospace and Defense Export Consortium held its first formal meeting on Wednesday, just as many of its members are starting to feel the effects of the across-the-board federal spending cuts that began March 1. New Hampshire has about 300 aerospace and defense-related companies, and the industry is growing, but it is also deeply affected by what happens in Washington, said Christopher Way, interim director of the state Division of Economic Development. ‘‘We’re seeing the hiring that’s starting to flatten. We’re seeing expansions that aren’t occurring and we’re also seeing contracts that aren’t being offered,’’ he said.
 
 

TODAY'S DEAL »

Spice of Melrose

 
Spice of Melrose: $20 for $40 worth of authentic Thai cuisine

Get this deal:


 
 
Connect with Boston.com

Facebook/Boston.com Twitter/Boston.com Business LinkedIn/Boston.com Image Map

FROM AROUND THE WEB




?

No comments:

Post a Comment